Product Description: Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Oh CK, et al. Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma. Inflamm Allergy Drug Targets. 2011 Jun;10(3):180-6.
CAS Number: 909875-08-7
Molecular Weight: N/A
Compound Purity: 99.23
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Interleukin Related